GF
Gabelli Funds Portfolio holdings
AUM
$14.1B
1-Year Return
24.08%
This Quarter Return
+9.25%
1 Year Return
+24.08%
3 Year Return
+81.74%
5 Year Return
+169.49%
10 Year Return
+407.67%
AUM
$14.1B
AUM Growth
+$963M
(+7.3%)
Cap. Flow
-$27.3M
Cap. Flow
% of AUM
-0.19%
Top 10 Holdings %
Top 10 Hldgs %
12.86%
Holding
1,292
New
192
Increased
280
Reduced
411
Closed
65
Top Buys
| 1 |
SWTX
SpringWorks Therapeutics
SWTX
|
$30.2M |
| 2 |
BPMC
Blueprint Medicines
BPMC
|
$27.1M |
| 3 |
Skechers
SKX
|
$18.6M |
| 4 |
FARO
Faro Technologies
FARO
|
$16.8M |
| 5 |
DNB
Dun & Bradstreet
DNB
|
$13.2M |
Top Sells
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$43M |
| 2 |
BECN
Beacon Roofing Supply, Inc.
BECN
|
$20.6M |
| 3 |
DFS
Discover Financial Services
DFS
|
$18M |
| 4 |
Newmont
NEM
|
$17.6M |
| 5 |
FNA
Paragon 28, Inc.
FNA
|
$16.8M |
Sector Composition
| 1 | Industrials | 20.93% |
| 2 | Financials | 12.81% |
| 3 | Communication Services | 10.18% |
| 4 | Technology | 10.08% |
| 5 | Utilities | 9.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
BP
BP
$87.4B
| $10.7M | 0.08% |
359,150
+350
| +0.1% | +$10.5K |
|
302
Liberty Media Series A
FWONA
$22.6B
| $10.7M | 0.08% |
112,750
-2,400
| -2% | -$228K |
|
303
W.R. Berkley
WRB
$27.3B
| $10.7M | 0.08% |
145,348
-3,124
| -2% | -$230K |
|
304
Synovus
SNV
$7.15B
| $10.6M | 0.08% |
205,016
+128,816
| +169% | +$6.67M |
|
305
Liberty Global Class C
LBTYK
$4.12B
| $10.6M | 0.08% |
1,028,264
-86,000
| -8% | -$887K |
|
306
Zimmer Biomet
ZBH
$20.9B
| $10.5M | 0.07% |
115,450
+4,500
| +4% | +$410K |
|
307
Vulcan Materials
VMC
$39B
| $10.5M | 0.07% |
40,310
+5,810
| +17% | +$1.52M |
|
308
Archer Daniels Midland
ADM
$30.2B
| $10.5M | 0.07% |
198,600
-3,800
| -2% | -$201K |
|
309
RPC Inc
RES
$1.04B
| $10.4M | 0.07% |
2,207,477
-61,938
| -3% | -$293K |
|
|
ORLA
310
Orla Mining
ORLA
$3.82B
| $10.3M | 0.07% |
1,025,800
+525,800
| +105% | +$5.27M |
|
311
Vodafone
VOD
$28.5B
| $10.2M | 0.07% |
960,300
-1,500
| -0.2% | -$16K |
|
312
Thermo Fisher Scientific
TMO
$186B
| $10.2M | 0.07% |
25,035
| – | – |
|
313
ICU Medical
ICUI
$3.24B
| $10.1M | 0.07% |
76,500
+6,000
| +9% | +$793K |
|
314
M&T Bank
MTB
$31.2B
| $10.1M | 0.07% |
51,907
-1,158
| -2% | -$225K |
|
315
EchoStar
SATS
$19.3B
| $9.97M | 0.07% |
359,805
+70,000
| +24% | +$1.94M |
|
316
Devon Energy
DVN
$22.1B
| $9.83M | 0.07% |
309,000
-4,400
| -1% | -$140K |
|
317
Valero Energy
VLO
$48.7B
| $9.82M | 0.07% |
73,077
+9,677
| +15% | +$1.3M |
|
318
Molson Coors Class B
TAP
$9.96B
| $9.77M | 0.07% |
203,232
+62,632
| +45% | +$3.01M |
|
319
Oil-Dri
ODC
$934M
| $9.69M | 0.07% |
164,200
-1,000
| -0.6% | -$59K |
|
|
ESGR
320
DELISTED
Enstar Group
ESGR
| $9.67M | 0.07% |
28,763
| – | – |
|
321
Tredegar Corp
TG
$273M
| $9.62M | 0.07% |
1,093,615
-3,600
| -0.3% | -$31.7K |
|
322
Novartis
NVS
$251B
| $9.61M | 0.07% |
79,400
-500
| -0.6% | -$60.5K |
|
323
Bio-Rad Laboratories Class A
BIO
$8B
| $9.6M | 0.07% |
39,800
-500
| -1% | -$121K |
|
324
BorgWarner
BWA
$9.53B
| $9.46M | 0.07% |
282,500
-6,500
| -2% | -$218K |
|
|
VIGL
325
DELISTED
Vigil Neuroscience
VIGL
| $9.46M | 0.07% |
+1,189,528
| New | +$9.46M |
|